What Researchers Did
Researchers reviewed past medical records of children with cancer who received hyperbaric oxygen therapy for superficial soft tissue lesions.
What They Found
Out of 12 pediatric cancer patients treated with HBOT for superficial soft tissue lesions, 10 (83%) were cured. Compliance with therapy was nearly 100%, and HBOT was found to be safe and effective for most patients, including those with weakened immune systems.
What This Means for Canadian Patients
For Canadian children undergoing cancer treatment who develop superficial soft tissue lesions, this study suggests that hyperbaric oxygen therapy could be a safe and effective supportive treatment option. It may help heal these lesions and improve patient comfort during a challenging time.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a retrospective study with a small sample size of 12 patients, these findings may not apply to all children with similar conditions.